Parkinson's Blog | Rengifo Parkinson's Foundation
-
New Parkinson's Medication: FDA Approves Tavapadon (Juvmo) in 2026
In September 2026 the FDA approved tavapadon (Juvmo), a once-daily Parkinson's medication that works on dopamine receptors in a new way. Here's what families should know.